Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 720

Sort by

Sort Order Select

Journal Articles

The CLUE Post-Surgery VTE Risk Instrument for Abdominal and Pelvic Surgery: Validation of Patient Risk Factor Component

Kari A.O. Tikkinen, Deborah M Siegal, PJ Devereaux, Sara V Tornberg, Flavia K Borges, Sandra Ofori, Jehonathan Pinthus, Bobby Shayegan, Lauri I Lavikainen, Gordon H Guyatt, Pavel S Roshanov

Blood Adv bloodadvances.2024015515.

https://doi.org/10.1182/bloodadvances.2024015515

Published: 2025

Journal Articles

Global Survey on Practice Changes and Barriers to the Use of Direct Oral Anticoagulants in Children

Laura Avila, Erica Di Ruggiero, Jennifer Vincelli, Leonardo R. Brandão

Blood Adv bloodadvances.2025016681.

https://doi.org/10.1182/bloodadvances.2025016681

Published: 2025

Includes: Supplemental data

Journal Articles

Clarifying the Role of p.Gln723Lys in hTTP Prevalence

Omid Seidizadeh, Andrea Cairo, Ilaria Mancini, James N George, Flora Peyvandi

Blood Adv bloodadvances.2025016030.

https://doi.org/10.1182/bloodadvances.2025016030

Published: 2025

Journal Articles

2025 ASH ISTH NBDF WFH Monitoring Report on Their 2021 Guidelines on Diagnosis and Management of von Willebrand Disease

Paula D. James, Veronica H Flood, Nathan T Connell

Blood Adv bloodadvances.2025016512.

https://doi.org/10.1182/bloodadvances.2025016512

Published: 2025

Journal Articles

Metabolically aberrant extracellular mitochondria induce oxidative endotheliopathy in traumatic brain injury

Xiaoxi Lu, Lujia Tang, Yingang Wu, Tristan Hilton, Xin Chen, Katie Houck, Sarah Fulton, Cha Han, Sophia Romero, Yi Wang, Rosemary Kozar, Jessica C. Cardenas, Xiaoyun Fu, Jianning Zhang, Zilong Zhao, Jing-fei Dong

Blood Adv (2025) 9 (9): 2079–2090.

https://doi.org/10.1182/bloodadvances.2024015296

Published: 2025

Includes: Supplemental data

Journal Articles

Red blood cell aggregation within a blood clot causes platelet-independent clot shrinkage

Alina D Peshkova, Ekaterina K Rednikova, Rafael R Khismatullin, Oleg V. Kim, Vladimir R Muzykantov, Prashant K Purohit, Rustem I Litvinov, John W. Weisel

Blood Adv bloodadvances.2024015533.

https://doi.org/10.1182/bloodadvances.2024015533

Published: 2025

Includes: Supplemental data

Journal Articles

Recurrent Thrombosis and Major Bleeding in Children Treated for VTE

Stephanie F Lenahan, Anne Blackmore, Matthew Fenchel, Evan Thomas, Joseph S. Palumbo, Cristina Tarango

Blood Adv bloodadvances.2025016135.

https://doi.org/10.1182/bloodadvances.2025016135

Published: 2025

Journal Articles

A model of zymogen factor XII: insights into protease activation

Aleksandr Shamanaev, Yujie Ma, Michal B. Ponczek, Mao-fu Sun, Quifang Cheng, S. Kent Dickeson, Owen J. T. McCarty, Jonas Emsley, Bassem M. Mohammed, David Gailani

Blood Adv (2025) 9 (8): 1940–1951.

https://doi.org/10.1182/bloodadvances.2025015842

Published: 2025

Includes: Supplemental data

Journal Articles

Patient anti-FVIII drug antibodies bind preferentially to a subset of FVIII covalent states

Diego Butera, Aster E Pijning, Nathan G Avery, Carmen Helena Coxon, Clive Metcalfe, Angelina Mimoun, Sebastien Lacroix-Desmazes, Paul Clinton Spiegel, Jr, Philip J Hogg

Blood Adv bloodadvances.2025016474.

https://doi.org/10.1182/bloodadvances.2025016474

Published: 2025

Includes: Supplemental data

Journal Articles

Unraveling antibody-induced structural dynamics in the ADAMTS13 CUB1-2 domains via HDX-MS

Quintijn Bonnez, Emily R. Legan, Inge Pareyn, Febe Boudry, Jennifer Anckaert, Claudia Tersteeg, Simon F. De Meyer, Renhao Li, Karen Vanhoorelbeke

Blood Adv (2025) 9 (8): 1763–1771.

https://doi.org/10.1182/bloodadvances.2024014950

Published: 2025

Includes: Supplemental data

Journal Articles

Platelet spleen tyrosine kinase is a key regulator of anti-PF4 antibody–induced immunothrombosis

Jan Zlamal, Vera M. Ripoll, Christine S.M. Lee, Filip Toma, Karina Althaus, Flavianna Rigoni, Andreas Witzemann, Shane Whittaker, David Capraro, Günalp Uzun, Tamam Bakchoul, Vivien M. Chen

Blood Adv (2025) 9 (8): 1772–1785.

https://doi.org/10.1182/bloodadvances.2024014167

Published: 2025

Includes: Supplemental data

Journal Articles

Agents of shield: glycans mask antibody epitopes on ADAMTS13

Colin A. Kretz

Blood Adv (2025) 9 (7): 1726–1727.

https://doi.org/10.1182/bloodadvances.2025015862

Published: 2025

Journal Articles

N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP

Tim Postmus, Nelly Schilder, Juliana Ferreira de Santana, Pieter Langerhorst, Paul Kaijen, Paul Coppo, Bérangère S. Joly, Agnès Veyradier, Karen Vanhoorelbeke, Jan Voorberg

Blood Adv (2025) 9 (7): 1728–1737.

https://doi.org/10.1182/bloodadvances.2024014298

Published: 2025

Includes: Supplemental data

Journal Articles

Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis

Blood Adv (2025) 9 (7): 1742–1761.

https://doi.org/10.1182/bloodadvances.2024015371

Published: 2025

Includes: Supplemental data

Journal Articles

Discrepancy between original and adapted ASH VTE guidelines: same clinical evidence but different recommendations.

Suely Meireles Rezende, Ignacio Neumann, Benjamin Djulbegovic

Blood Adv bloodadvances.2025016102.

https://doi.org/10.1182/bloodadvances.2025016102

Published: 2025

Includes: Supplemental data

Journal Articles

Platelet activating histone/antihistone IgG complexes in anti-PF4 negative thrombosis and thrombocytopenia syndrome.

Blood Adv bloodadvances.2024015076.

https://doi.org/10.1182/bloodadvances.2024015076

Published: 2025

Includes: Supplemental data

Journal Articles

American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary

Blood Adv (2025) 9 (6): 1247–1260.

https://doi.org/10.1182/bloodadvances.2024014219

Published: 2025

Includes: Supplemental data

Journal Articles

Development of a protease-resistant ADAMTS13 to improve stability against proteolytic degradation

Veronica DeYoung, Rex Huang, Hasam Madarati, Rida Malik, Peter Anthony Andrisani, Cherie Teney, Colin A. Kretz

Blood Adv bloodadvances.2024015212.

https://doi.org/10.1182/bloodadvances.2024015212

Published: 2025

Includes: Supplemental data

Journal Articles

Venous Thrombosis Unchained: Pandora's Box of Non-Inflammatory Mechanisms

Sophie Robyn Megan Smith, Neil V. Morgan, Alexander Brill

Blood Adv bloodadvances.2024014114.

https://doi.org/10.1182/bloodadvances.2024014114

Published: 2025

Journal Articles

Validation of Risk Assessment Models for Venous Thromboembolism in Cancer Patients Receiving Systemic Therapies

Nikola Vladić, Cornelia Englisch, Julia Maria Berger, Florian Moik, Anna Sophie Berghoff, Matthias Preusser, Ingrid Pabinger, Cihan Ay

Blood Adv bloodadvances.2025016044.

https://doi.org/10.1182/bloodadvances.2025016044

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

The CLUE Post-Surgery VTE Risk Instrument for Abdominal and Pelvic Surgery: Validation of Patient Risk Factor Component

Global Survey on Practice Changes and Barriers to the Use of Direct Oral Anticoagulants in Children

Clarifying the Role of p.Gln723Lys in hTTP Prevalence

2025 ASH ISTH NBDF WFH Monitoring Report on Their 2021 Guidelines on Diagnosis and Management of von Willebrand Disease

Metabolically aberrant extracellular mitochondria induce oxidative endotheliopathy in traumatic brain injury

Red blood cell aggregation within a blood clot causes platelet-independent clot shrinkage

Recurrent Thrombosis and Major Bleeding in Children Treated for VTE

A model of zymogen factor XII: insights into protease activation

Patient anti-FVIII drug antibodies bind preferentially to a subset of FVIII covalent states

Unraveling antibody-induced structural dynamics in the ADAMTS13 CUB1-2 domains via HDX-MS

Platelet spleen tyrosine kinase is a key regulator of anti-PF4 antibody–induced immunothrombosis

Agents of shield: glycans mask antibody epitopes on ADAMTS13

N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP

Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis

Discrepancy between original and adapted ASH VTE guidelines: same clinical evidence but different recommendations.

Platelet activating histone/antihistone IgG complexes in anti-PF4 negative thrombosis and thrombocytopenia syndrome.

American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary

Development of a protease-resistant ADAMTS13 to improve stability against proteolytic degradation

Venous Thrombosis Unchained: Pandora's Box of Non-Inflammatory Mechanisms

Validation of Risk Assessment Models for Venous Thromboembolism in Cancer Patients Receiving Systemic Therapies

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only